ArticleBMJ paediatrics open2025

Multicentre study on nirsevimab: Bayesian analysis reveals persisting risk for preterm infants.

Enrico Cocchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.